Suchergebnisse - "Yokote, Koutaro"

PubPharm (594)

1

Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients

enthalten in: Journal of clinical immunology | 2024

von Aoki, A. | Iwamura, C. | Kiuchi, M. | +33

2

Efficacy and Safety of Pemafibrate Extended-Release Tablet : a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial

enthalten in: Journal of atherosclerosis and thrombosis | 2024

von Arai, H. | Yamashita, S. | Araki, E. | +6

3

Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression

enthalten in: Leukemia | 2024

von Matsui, S. | Ri, C. | Bolanos, L. | +13

4

Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy

enthalten in: Clinical nuclear medicine | 2024

von Ruike, Y. | Suzuki, S. | Yokote, K.

5

Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients

enthalten in: Journal of clinical immunology | 2024

von Aoki, A. | Iwamura, C. | Kiuchi, M. | +33

6

Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan

enthalten in: Endocrine journal | 2024

von Ogawa, W. | Hirota, Y. | Miyazaki, S. | +6

7

ANTISENSE OLIGOMER

enthalten in: Europäisches Patentamt | 2024

von YOKOTE KOUTARO | OUCHI YASUO | KATO HISAYA | +2

8

Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use : A cohort study using the Japanese health insurance claims database

enthalten in: Diabetes, obesity & metabolism | 2024

von Ishibashi, R. | Inaba, Y. | Koshizaka, M. | +9

9

Familial hypercholesterolemia with special focus on Japan

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Kobayashi, J. | Minamizuka, T. | Tada, H. | +1

10

Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia : A Phase III, Multi-center, Open-label Trial

enthalten in: Journal of atherosclerosis and thrombosis | 2024

von Ako, J. | Yokote, K. | Tsujita, K. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[60]